Single-use bioprocessing technology has gained significant traction in recent years, owing to the rapid adoption of disposable bioprocessing equipment by pharmaceutical manufacturers. This has fueled the manufacturers to integrate different materials in the construction of single-use bioprocessing products. These products have also proved beneficial for the small scale pharmaceutical manufacturers.

Hence, most biopharmaceutical companies utilize single-use bioprocessing technology for manufacturing vaccines, monoclonal antibodies, and other pharmaceutical components on a commercial scale. This has spurred the demand for high-grade plastic and silicone materials in the development of SUB products.

Download Sample @ www.alliedmarketresearch.com/request-sample/4600?utm_sour...

The global single-use bioprocessing material market was valued at $2,800.0 million in 2016 and is projected to reach $9,342.1 million by 2023, growing at a CAGR of 18.7% from 2017 to 2023. The plastic segment accounted for a five-eighths share of the global market in 2016.

The polyethylene segment is the major contributor to the revenue generated by the plastic segment is 2016 and is anticipated to maintain this dominance throughout the forecast period. Variants of polyethylene, such as high-density polyethylene (HDPE), low-density polyethylene (LDPE), and medium-density polyethylene (MDPE) are used to manufacture single-use bioprocessing products. In addition, polyethylene is extensively used in the construction of media bags along with the films used in the bioprocess containers.

Moreover, biopharmaceutical manufacturers segment has dominated the global market in 2016 and is anticipated to maintain this trend throughout the forecast period. The major driving force of the increasing utilization of single-use bioprocessing systems is the collaboration between leading manufacturers and small-scale suppliers of filtration, container or closure systems, mixing systems, fermentation systems, and cell culture systems (bioreactors).

Major Players:

• Thermo Fisher Scientific
• Danaher Corporation
• GE Healthcare (General Electric Company)
• Sartorius Stedim Biotech S.A
• Merck Millipore (Merck Group)
• 3M Company
• Eppendorf AG
• Finesse Solutions Inc.
• Applikon Biotechnology B.V.

Key Findings of the Single-use Bioprocessing Material Market:

• The silicone material segment accounted for the second largest share in the global market in 2016 and is expected to maintain this trend throughout the forecast period.
• Other plastic material segment is anticipated to grow at the fastest pace from 2017-2023.
• Contract research organization & manufacturers registered the highest growth in the global single-use bioprocessing material market during the forecast period.
• North America dominated the single-use bioprocessing material market in 2016 and is anticipated to maintain this trend throughout the forecast period.
• UK is anticipated to grow at the fastest pace in the European single-use bioprocessing market during the forecast period.

Flat 20% Discount on All License Type ..

www.alliedmarketresearch.com/checkout/578629?utm_source=o...

* Offer Valid Till 20th April 2019

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.